Randomized Phase II Study of Bortezomib, Lenalidomide, and Dexamethasone (VRD) Versus Lenalidomide and Dexamethasone (RD) in Elderly Patients with Newly Diagnosed Multiple Myeloma (KMM1910)
Cancer Research and Treatment · 29.05.2026
DOI: 10.4143/crt.2026.0255 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Research and Treatment, online erschienen am 29.05.2026. Verfasst von Jun Ho Yi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Division of Hematology-Oncology, Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea.
- Division of Hematology-Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
- Division of Hematology-Oncology, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Korea.
- Division of Hematology-Oncology, Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea.
- Division of Hematology-Oncology, Department of Internal Medicine, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea.
Zitieren
APA
Yi, J. H., Yoon, S. E., Lee, J. H., Bang, S. M., Lee, M. W., Moon, J. H., Lee, J. J., Eom, H. S., Min, C. K., Do, Y. R., Lim, S., Shin, H. J., Lee, J. H., Kim, H. J., Yoon, S. S., & Kim, K. (2026). Randomized Phase II Study of Bortezomib, Lenalidomide, and Dexamethasone (VRD) Versus Lenalidomide and Dexamethasone (RD) in Elderly Patients with Newly Diagnosed Multiple Myeloma (KMM1910). Cancer Research and Treatment. https://doi.org/10.4143/crt.2026.0255
Vancouver
Yi JH, Yoon SE, Lee JH, Bang SM, Lee MW, Moon JH, et al. Randomized Phase II Study of Bortezomib, Lenalidomide, and Dexamethasone (VRD) Versus Lenalidomide and Dexamethasone (RD) in Elderly Patients with Newly Diagnosed Multiple Myeloma (KMM1910). Cancer Research and Treatment. 2026. doi:10.4143/crt.2026.0255
BibTeX
@article{Yi2026,
author = {Yi, Jun Ho and Yoon, Sang Eun and Lee, Ji Hyun and Bang, Soo Mee and Lee, Myung-Won and Moon, Joon Ho and Lee, Je-Jung and Eom, Hyeon-Seok and Min, Chang-Ki and Do, Young Rok and Lim, Sungnam and Shin, Ho-Jin and Lee, Jae Hoon and Kim, Hyo Jung and Yoon, Sung-Soo and Kim, Kihyun},
title = {Randomized Phase II Study of Bortezomib, Lenalidomide, and Dexamethasone (VRD) Versus Lenalidomide and Dexamethasone (RD) in Elderly Patients with Newly Diagnosed Multiple Myeloma (KMM1910)},
journal = {Cancer Research and Treatment},
year = {2026},
doi = {10.4143/crt.2026.0255}
}
EUVIMED